NPEPL1: Aminopeptidase-like 1 as A Drug Target Or Biomarker (G79716)

Target Name: NPEPL1

NCBI ID: G79716

NPEPL1

NPEPL1: Aminopeptidase-like 1 as A Drug Target Or Biomarker

NPEPL1 (Aminopeptidase-like 1) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and muscles. It is a member of the superfamily of proteins known as AP-1 (Aminopeptidase-like), and is characterized by the presence of a unique catalytic active site and a distinct 尾-sheet region.

NPEPL1 has been shown to play a critical role in the regulation of a variety of cellular processes, including metabolism, inflammation, and neurodegeneration. Its functions have been attributed to its ability to catalyze the hydrolysis of peptides and other short chains, as well as its role in modulating the levels of various cellular signaling pathways.

Due to its unique structure and the diverse functions that it has been shown to play, NPEPL1 has potential as a drug target or biomarker. Many studies have investigated the potential therapeutic benefits of targeting NPEPL1, with the goal of using its unique properties to treat a variety of diseases.

One of the main reasons for the interest in NPEPL1 as a drug target is its ability to modulate the levels of various signaling pathways. For example, NPEPL1 has been shown to play a critical role in the regulation of the JAK/STAT3 signaling pathway, which is involved in the regulation of immune and inflammatory responses.

In addition to its role in modulating signaling pathways, NPEPL1 has also been shown to play a critical role in the regulation of cellular metabolism. For example, it has been shown to play a role in the metabolism of amino acids, which are essential for the maintenance of cellular life.

NPEPL1 has also been shown to play a role in the regulation of cellular stress responses. It has been shown to be involved in the regulation of cellular stress responses, which are critical for the maintenance of cellular health and homeostasis.

Due to its diverse functions, NPEPL1 has the potential to be a valuable drug target or biomarker for a variety of diseases. Many studies are currently being conducted to investigate the potential therapeutic benefits of targeting NPEPL1, with the goal of using its unique properties to treat a variety of diseases.

In conclusion, NPEPL1 (Aminopeptidase-like 1) is a protein that is expressed in various tissues throughout the body, and is characterized by its unique catalytic active site and distinct 尾-sheet region. It has been shown to play a critical role in the regulation of a variety of cellular processes, including metabolism, inflammation, and neurodegeneration. Its functions have been attributed to its ability to catalyze the hydrolysis of peptides and other short chains, as well as its role in modulating the levels of various cellular signaling pathways. As a result, NPEPL1 has potential as a drug target or biomarker for a variety of diseases.

Protein Name: Aminopeptidase Like 1

Functions: Probably catalyzes the removal of unsubstituted N-terminal amino acids from various peptides

The "NPEPL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPEPL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets